Colossal Biosciences raises $200M at $10.2B valuation to revive woolly mammoths and other extinct species
In a fitting move for a company focused on bringing extinct species back to life, Dallas-based Colossal Biosciences has raised $200 million in Series C funding, becoming Texas’ first “decacorn,” a term for private companies valued at over $10 billion.
The post Colossal Biosciences raises $200M at $10.2B valuation to revive woolly mammoths and other extinct species first appeared on Tech Startups.
In a fitting move for a company focused on bringing extinct species back to life, Dallas-based Colossal Biosciences has raised $200 million in Series C funding, becoming Texas’ first “decacorn,” a term for private companies valued at over $10 billion. […]
The post Colossal Biosciences raises $200M at $10.2B valuation to revive woolly mammoths and other extinct species first appeared on Tech Startups.